| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | L256JB984D |
| InChI Key | SHZKQBHERIJWAO-AATRIKPKSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C13H12N2O2 |
| Molecular Weight | 228.25 |
| AlogP | 2.03 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 55.12 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 17.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 5
Cytochrome P450 family 5A
Cytochrome P450 5A1
|
- | 24-10000 | - | - | 89-89 | |
|
Enzyme
Oxidoreductase
|
- | - | - | - | 21-24 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Dry Eye Syndromes | 3 | D015352 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 134938 |
| ChEMBL | CHEMBL11662 |
| DrugBank | DB12017 |
| DrugCentral | 2043 |
| EPA CompTox | DTXSID6048547 |
| FDA SRS | L256JB984D |
| Guide to Pharmacology | 9866 |
| PubChem | 5282440 |
| SureChEMBL | SCHEMBL4210 |
| ZINC | ZINC000000005389 |